MedTrace Logo

Repeat Late GDM Testing and Cesarean Delivery Rates

NCT07708129 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2026-07-16

No results posted yet for this study

Summary

The goal of this randomized trial is determine if re-testing for gestational diabetes in the third trimester after an ultrasound measurement of estimated fetal weight (EFW) or abdominal circumference greater than 90%ile decreases cesarean delivery rate, and to evaluate the optimal method of re-testing. The main question it aims to answer is:

Does repeat testing for gestational diabetes and management of hyperglycemia decrease the cesarean delivery rate in fetuses measuring \>90%ile by estimated fetal weight (EFW) or abdominal circumference (AC) on ultrasound in the third trimester.

Participants will be randomized into two groups: Group 1 will undergo a repeat glucose tolerance test (GTT) with blinded continuous glucose monitor (CGM) and group 2 will have no intervention. Participants in group 1 will receive nutrition counseling as this would be standard in patients at high risk for gestational diabetes.

Conditions

  • Large for Gestational Age (LGA)
  • Pregnancy

Interventions

DIAGNOSTIC_TEST

Glucose tolerance test and continuous glucose monitor

1. Glucose tolerance test 2. Continuous glucose monitoring for two weeks 3. Nutrition counseling

Sponsors & Collaborators

  • Shauna F. Williams, MD

    lead OTHER

Principal Investigators

  • Shauna Williams, MD · Rutgers Health New Jersey Medical School

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-08-01
Primary Completion
2028-04-30
Completion
2028-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07708129 on ClinicalTrials.gov